Mar Riveiro-Barciela Selected Research

Ribavirin (Virazole)

11/2018	Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin.
10/2018	Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.
2/2015	Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion.
11/2013	Hepatitis E virus: new faces of an old infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mar Riveiro-Barciela Research Topics

Disease

32	Infections 12/2023 - 11/2013
17	Hepatitis B 01/2024 - 07/2015
15	Chronic Hepatitis B 12/2022 - 07/2015
14	Fibrosis (Cirrhosis) 12/2023 - 11/2013
10	Hepatitis 01/2024 - 02/2015
10	Liver Diseases (Liver Disease) 12/2023 - 11/2013
8	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 01/2014
8	Chronic Hepatitis (Chronic Active Hepatitis) 12/2023 - 01/2016
8	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 01/2017
6	COVID-19 11/2023 - 01/2020
6	Hepatitis E 01/2023 - 11/2013
6	Viremia 12/2021 - 02/2018
5	Neoplasms (Cancer) 01/2024 - 12/2020
5	Autoimmune Hepatitis 12/2023 - 01/2020
4	Hepatitis C 10/2023 - 12/2015
4	Persistent Infection 01/2023 - 05/2018
3	Chronic Hepatitis D 12/2023 - 01/2021
3	Coinfection 01/2023 - 01/2021
2	Colitis 01/2024 - 01/2024
2	HIV Infections (HIV Infection) 12/2023 - 01/2014
2	Inflammation (Inflammations) 11/2023 - 01/2022
2	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 10/2020
2	Fatty Liver 12/2021 - 01/2021
2	Disease Progression 05/2020 - 01/2020
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023
1	Breakthrough Infections 11/2023
1	Chronic Renal Insufficiency 10/2023
1	Multiple Sclerosis 09/2023
1	Neuromyelitis Optica (Devic's Disease) 09/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Asymptomatic Infections 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2022
1	Hepatitis D 10/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Reinfection 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Ascites 01/2022

Drug/Important Bio-Agent (IBA)

16	RNA (Ribonucleic Acid)IBA 01/2024 - 02/2015
14	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2024 - 07/2015
13	Antiviral Agents (Antivirals)IBA 10/2023 - 01/2017
9	Hepatitis B e AntigensIBA 10/2023 - 07/2015
7	Immunoglobulin G (IgG)IBA 12/2023 - 01/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2020
7	Tenofovir (Viread)FDA Link 12/2022 - 07/2015
6	Immune Checkpoint InhibitorsIBA 01/2024 - 03/2021
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2020
6	AntigensIBA 01/2023 - 01/2020
6	Immunoglobulin M (IgM)IBA 01/2023 - 02/2015
5	entecavir FDA Link 12/2022 - 01/2017
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 01/2020
4	InterferonsIBA 01/2022 - 11/2013
4	Ribavirin (Virazole)FDA LinkGeneric 11/2018 - 11/2013
3	Transaminases (Aminotransferases)IBA 12/2023 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2019
3	AntibodiesIBA 09/2023 - 02/2015
3	NucleotidesIBA 11/2022 - 07/2016
3	tenofovir alafenamideIBA 01/2021 - 11/2017
2	bulevirtideIBA 12/2023 - 01/2022
2	VaccinesIBA 11/2023 - 11/2013
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 01/2020
2	Rituximab (Mabthera)FDA Link 09/2023 - 01/2019
2	Alanine Transaminase (SGPT)IBA 12/2021 - 01/2021
2	NucleosidesIBA 11/2021 - 07/2016
2	Surface Antigens (Surface Antigen)IBA 01/2021 - 07/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2023
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 12/2023
1	MTOR InhibitorsIBA 12/2023
1	EnzymesIBA 12/2023
1	Viral VaccinesIBA 11/2023
1	Lymphotoxin-alpha (Lymphotoxin)IBA 11/2023
1	mRNA VaccinesIBA 11/2023
1	Messenger RNA (mRNA)IBA 11/2023
1	AlbuminsIBA 11/2023
1	ocrelizumabIBA 09/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	Antinuclear AntibodiesIBA 01/2023
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022
1	TroponinIBA 10/2022
1	Immunoglobulins (Immunoglobulin)IBA 10/2022
1	SteroidsIBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	BilirubinIBA 12/2021

Therapy/Procedure

29	Therapeutics 01/2024 - 11/2013
5	Liver Transplantation 11/2023 - 01/2014
4	Immunotherapy 01/2023 - 12/2020
3	Aftercare (After-Treatment) 01/2022 - 07/2015
2	Transplantation 01/2022 - 01/2014
1	Renal Dialysis (Hemodialysis) 12/2023
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2023
1	Retreatment 01/2023
1	Kidney Transplantation 01/2022